Free Trial

The Cooper Companies, Inc. (NASDAQ:COO) Receives Average Recommendation of "Moderate Buy" from Analysts

Cooper Companies logo with Medical background
Remove Ads

Shares of The Cooper Companies, Inc. (NASDAQ:COO - Get Free Report) have received an average recommendation of "Moderate Buy" from the ten ratings firms that are currently covering the firm, Marketbeat Ratings reports. Three equities research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. The average 1-year price objective among analysts that have covered the stock in the last year is $110.25.

A number of brokerages recently issued reports on COO. Wells Fargo & Company raised their price objective on shares of Cooper Companies from $115.00 to $118.00 and gave the company an "overweight" rating in a report on Friday, December 6th. Citigroup cut their price target on shares of Cooper Companies from $115.00 to $110.00 and set a "buy" rating on the stock in a report on Friday, March 7th. Morgan Stanley decreased their price objective on Cooper Companies from $104.00 to $102.00 and set an "equal weight" rating for the company in a report on Friday, December 6th. StockNews.com downgraded Cooper Companies from a "buy" rating to a "hold" rating in a report on Wednesday, December 11th. Finally, Needham & Company LLC reissued a "hold" rating on shares of Cooper Companies in a research note on Friday, March 7th.

View Our Latest Analysis on Cooper Companies

Remove Ads

Cooper Companies Price Performance

Shares of COO traded down $1.21 during mid-day trading on Tuesday, reaching $83.77. The company had a trading volume of 1,736,366 shares, compared to its average volume of 1,343,865. The company has a market capitalization of $16.75 billion, a price-to-earnings ratio of 42.96, a P/E/G ratio of 2.25 and a beta of 1.02. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.12 and a current ratio of 1.91. The company's 50 day simple moving average is $89.33 and its 200 day simple moving average is $97.36. Cooper Companies has a 1-year low of $77.05 and a 1-year high of $112.38.

Cooper Companies (NASDAQ:COO - Get Free Report) last issued its earnings results on Thursday, March 6th. The medical device company reported $0.92 earnings per share for the quarter, meeting analysts' consensus estimates of $0.92. The firm had revenue of $964.70 million for the quarter, compared to analyst estimates of $981.25 million. Cooper Companies had a net margin of 10.07% and a return on equity of 9.38%. Analysts expect that Cooper Companies will post 3.98 EPS for the current year.

Institutional Investors Weigh In On Cooper Companies

Several institutional investors have recently added to or reduced their stakes in the business. Byrne Asset Management LLC purchased a new position in Cooper Companies in the 4th quarter valued at approximately $33,000. OFI Invest Asset Management purchased a new position in shares of Cooper Companies in the fourth quarter valued at $34,000. New Age Alpha Advisors LLC bought a new stake in shares of Cooper Companies during the 4th quarter valued at $38,000. Covestor Ltd lifted its holdings in Cooper Companies by 35.5% during the 4th quarter. Covestor Ltd now owns 458 shares of the medical device company's stock worth $42,000 after purchasing an additional 120 shares in the last quarter. Finally, Brown Brothers Harriman & Co. boosted its stake in Cooper Companies by 191.0% in the 3rd quarter. Brown Brothers Harriman & Co. now owns 419 shares of the medical device company's stock worth $46,000 after purchasing an additional 275 shares during the period. 24.39% of the stock is owned by hedge funds and other institutional investors.

Cooper Companies Company Profile

(Get Free Report

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.

Featured Stories

Analyst Recommendations for Cooper Companies (NASDAQ:COO)

Should You Invest $1,000 in Cooper Companies Right Now?

Before you consider Cooper Companies, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cooper Companies wasn't on the list.

While Cooper Companies currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Recent Videos

Time to Buy SoFi? Fintech’s Next Big Move
3 Chip Stocks Primed for a Comeback—Have They Found the Bottom?
Why Palantir’s Future Just Got a Massive Boost

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads